Tatva Chintan Pharma Chem Ltd's credit ratings were downgraded by CRISIL on 17 June 2025, from CRISIL A-/Negative to CRISIL BBB+/Stable for long-term facilities, and from CRISIL A2+ to CRISIL A2 for short-term facilities due to a moderation in the business risk profile.